T2 Biosystems Inc (TTOO)
3.40
-0.23
(-6.34%)
USD |
NASDAQ |
May 07, 12:53
T2 Biosystems Shareholders Equity (Quarterly): -28.04M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.04M |
| September 30, 2023 | -19.24M |
| June 30, 2023 | -36.42M |
| March 31, 2023 | -49.89M |
| December 31, 2022 | -39.66M |
| September 30, 2022 | -31.67M |
| June 30, 2022 | -37.52M |
| March 31, 2022 | -25.65M |
| December 31, 2021 | -12.90M |
| September 30, 2021 | -2.463M |
| June 30, 2021 | 9.009M |
| March 31, 2021 | -0.566M |
| December 31, 2020 | 8.726M |
| September 30, 2020 | 17.57M |
| June 30, 2020 | -4.388M |
| March 31, 2020 | -7.697M |
| December 31, 2019 | -34.00M |
| September 30, 2019 | -25.91M |
| June 30, 2019 | -15.62M |
| March 31, 2019 | -1.58M |
| December 31, 2018 | 11.39M |
| Date | Value |
|---|---|
| September 30, 2018 | 23.76M |
| June 30, 2018 | 31.98M |
| March 31, 2018 | -10.09M |
| December 31, 2017 | 1.34M |
| September 30, 2017 | 18.13M |
| June 30, 2017 | 12.32M |
| March 31, 2017 | 26.03M |
| December 31, 2016 | 39.34M |
| September 30, 2016 | 50.58M |
| June 30, 2016 | 22.66M |
| March 31, 2016 | 35.09M |
| December 31, 2015 | 46.94M |
| September 30, 2015 | 23.81M |
| June 30, 2015 | 34.05M |
| March 31, 2015 | 43.48M |
| December 31, 2014 | 53.00M |
| September 30, 2014 | 61.43M |
| June 30, 2014 | -106.98M |
| March 31, 2014 | 17.70M |
| December 31, 2013 | -89.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-49.89M
Minimum
Mar 2023
17.57M
Maximum
Sep 2020
-17.70M
Average
-19.24M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Abeona Therapeutics Inc | 14.83M |
| Pacific Biosciences of California Inc | 701.30M |
| INVO Bioscience Inc | 0.8928M |
| Sensus Healthcare Inc | 48.84M |
| Assure Holdings Corp | -15.34M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 34.80M |
| Total Liabilities (Quarterly) | 62.83M |
| Debt to Equity Ratio | -1.472 |
| Current Ratio | 0.4486 |
| Net Debt Paydown Yield | 6.21% |